Video

Assessing Psoriatic Arthritis Research For the Future

Author(s):

Philip Mease shared that he and his team are in the midst of preparing the content of the studies for publication to ensure continued education of psoriatic arthritis treatment.

Philip Mease shared that he and his team are in the midst of preparing the content of the studies for publication to ensure continued education about psoriatic arthritis treatment. Mease concluded, "We're very excited about this new data because this a patient population that historically has had few treatments at least until the anti-TNF medicines came along, and now we're finding that for patients who don't respond adequately to the anti-TNFs, it's important to have new mechanisms of action for treating this very important population of rheumatology patients."

Related Videos
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
A. Sidney Barritt, MD | Credit: UNC School of Medicine
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
© 2024 MJH Life Sciences

All rights reserved.